Rapid Communication - Journal of Parasitic Diseases: Diagnosis and Therapy (2024) Volume 9, Issue 4
Advances in Diagnosis and Management of Clinical Parasitic Diseases: Challenges and Future Prospects.
Article type: Rapid Communication
Home Page URL: https://www.alliedacademies.org/parasitic-diseases-diagnosis-therapy/
Journal short name: J Parasit Dis Diagn Ther
Volume: 9
Issue: 5
PDF No: 196
Citation: Collins A. Advances in Diagnosis and Management of Clinical Parasitic Diseases: Challenges and Future Prospects, J Parasit Dis Diagn Ther. 2024; 9(5):196
*Correspondence to: Department of Tropical Medicine, Harvard University, USA, E-mail: amandacollins.research@gmail.com
Received: 27-Sep-2024, Manuscript No. AAPDDT-24-154382; Editor assigned: 01-Oct-2024, PreQC No. AAPDDT-24-154382 (PQ); Reviewed: 15-Oct-2024, QC No. AAPDDT-24-154382; Revised: 22-Oct-2024, Manuscript No. AAPDDT-24-154382 (R); Published: 29-Oct-2024, DOI:10.35841/aapddt-9.5.196
Abstract
Parasitic diseases remain a significant global health burden, particularly in low- and middle-income countries. Despite substantial progress in understanding their pathophysiology and treatment, many parasitic infections still pose diagnostic and therapeutic challenges. This article reviews the current landscape of clinical parasitic diseases, including recent advances in diagnostics, therapeutic strategies, and emerging drug resistance. Additionally, we discuss future directions for research and control efforts to mitigate the impact of parasitic diseases worldwide.
Abstract
Parasitic diseases remain a significant global health burden, particularly in low- and middle-income countries. Despite substantial progress in understanding their pathophysiology and treatment, many parasitic infections still pose diagnostic and therapeutic challenges. This article reviews the current landscape of clinical parasitic diseases, including recent advances in diagnostics, therapeutic strategies, and emerging drug resistance. Additionally, we discuss future directions for research and control efforts to mitigate the impact of parasitic diseases worldwide.
Introduction
Parasitic infections affect millions globally, contributing to morbidity and mortality, especially in underdeveloped regions. These infections are caused by protozoa, helminths, and ectoparasites, each presenting unique clinical challenges. Diseases such as malaria, leishmaniasis, and schistosomiasis not only compromise public health but also place an economic burden on affected communities. Understanding the pathogenesis, improving diagnostic accuracy, and developing effective treatments are crucial for reducing the global impact of these diseases [1].
Overview of Key Clinical Parasitic Diseases
Malaria
Caused by Plasmodium species, malaria remains the most deadly parasitic disease. Advances in rapid diagnostic tests (RDTs) and the introduction of artemisinin-based combination therapies (ACTs) [2] have significantly improved outcomes. However, the rise of drug resistance poses new challenges [3].
Leishmaniasis
Leishmaniasis, caused by various Leishmania species [4], manifests in cutaneous, mucocutaneous, and visceral forms. Diagnostic innovations and therapeutic approaches, including liposomal amphotericin B, have improved treatment success rates [5].
Schistosomiasis
Schistosomiasis, caused by trematodes, affects millions in endemic regions. Mass drug administration (MDA) with praziquantel remains the primary control strategy [6]. However, reinfection rates remain high, highlighting the need for integrated control efforts [7].
Other Notable Diseases
Briefly discuss other significant parasitic diseases, such as trypanosomiasis, filariasis, and soil-transmitted helminths (STHs) [8, 9, 10].
Diagnostic Innovations
- Molecular Diagnostics: Role of PCR and next-generation sequencing.
- Point-of-Care Testing: Advances in RDTs for field diagnostics.
- Serological Methods: Improvements in sensitivity and specificity.
Therapeutic Advances and Challenges
- Current Treatments: Overview of drugs for key parasitic diseases.
- Drug Resistance: Mechanisms and impact on treatment outcomes.
- New Therapeutic Strategies: Research on novel drugs and combination therapies.
Future Prospects
- Vaccine Development: Progress and challenges in parasitic vaccines.
- Public Health Interventions: Integrated approaches and community-based programs.
- Technological Innovations: The role of AI and digital health in managing parasitic diseases.
Conclusion
Parasitic diseases remain a critical challenge in global health, requiring ongoing research and innovation. Advances in diagnostics and therapeutics have improved patient outcomes, but drug resistance and socio-economic factors continue to hinder progress. Collaborative efforts between governments, academia, and industry are essential for developing sustainable solutions and reducing the burden of parasitic diseases worldwide
References
Lawrence H, Hunter A, Murray R, et al. Cigarette smoking and the occurrence of influenza–Systematic review. J Infect. 2019;79:401-6.
Indexed at, Google Scholar, Cross Ref
Han L, Ran J, Mak YW, et al. Smoking and Influenza- associated Morbidity and Mortality A Systematic Review and Meta-analysis. Epidemiology. 2019;30:405-17.
Indexed at, Google Scholar, Cross Ref
Wang B, Li R, Lu Z, et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12:6049-57.
Indexed at, Google Scholar, Cross Ref
Ishikawa Y, Terao C. The impact of cigarette smoking on risk of rheumatoid arthritis: a narrative review. Cells. 2020;9(2):475.
Indexed at, Google Scholar, Cross Ref
Pierce JP, Chen R, Leas EC, et al. Use of e-cigarettes and other tobacco products and progression to daily cigarette smoking. Pediatrics. 2021;147(2).
Indexed at, Google Scholar, Cross Ref
Crompton DW (2001). Ascaris and ascariasis. Microbes Infect.2001; 3(4): 245-54.
Indexed at, Google Scholar, Cross Ref
Hotez PJ, Brindley, PJ, Bethony JM, et.al. (2008). Helminth infections: the great neglected tropical diseases. J Clin Invest.2008; 118(4): 1311-21.
Indexed at, Google Scholar, Cross Ref
Garcia LS. Diagnostic medical parasitology. American Society for Microbiology Press; 2006 Nov 29.
Indexed at, Google Scholar, Cross Ref
World Health Organization. Soil-transmitted helminth infections (2020). Retrieved from https://www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections
Moore J. Parasites and the Behavior of Animals. Oxford University Press (2002).